Imagine a world where diabetes no longer holds people back from living their fullest lives. That's the bold vision driving our mission, and in 2025, we took a giant leap forward by investing nearly £3 million into groundbreaking diabetes research. But here's where it gets exciting: this isn't just about numbers; it's about transforming lives through science and innovation.
Thanks to your incredible support, we're currently funding 112 cutting-edge diabetes research projects, with 16 new initiatives launched in 2025 alone. Your generosity is the fuel that powers our commitment to exceptional science and innovative ideas, all aimed at revolutionizing the lives of those living with diabetes. Every year, we push boundaries, exploring treatments, management strategies, and more, across all types of diabetes and its complications. And we're not just filling research gaps—we're addressing the specific needs of communities most affected by this condition.
And this is the part most people miss: our efforts extend far beyond individual projects. The Type 1 Diabetes Grand Challenge community is a thriving hub of innovation, with 23 pioneering projects involving 189 researchers and collaborators across 49 institutions in eight countries. In 2025 alone, Grand Challenge researchers published 28 groundbreaking studies in scientific journals. We also funded four new research teams dedicated to developing a reliable supply of insulin-producing beta cells from stem cells, a breakthrough that could accelerate the development of beta cell therapies to cure type 1 diabetes. But here's the controversial part: while stem cell research holds immense promise, it also raises ethical questions. What are your thoughts on the balance between scientific progress and ethical considerations?
Now, let's dive into some of the specific projects your support made possible in 2025.
Diabetes and Wellbeing: Unraveling a Complex Link
Diabetes isn't just a physical condition; it profoundly impacts emotional and psychological wellbeing. That's why supporting wellbeing is a key focus in our refreshed Research Strategy 2025-2030. We know there's a strong link between type 2 diabetes and depression, but the best way to treat both conditions simultaneously remains unclear. Enter Dr. Min Gao at the University of Oxford, whose research we began funding in 2025. Dr. Gao is analyzing studies on the effects of diabetes medications on depression and engaging directly with people living with type 2 diabetes and depression to understand their experiences and treatment expectations. Her work could lead to personalized treatment guidelines, helping individuals manage both blood sugar levels and depression, ultimately improving their quality of life. But here's a thought-provoking question: How can we ensure that mental health is given equal priority in diabetes care?
Tackling Inequity in Women's Health: A Nuanced Approach
Diabetes doesn't affect everyone equally, and our Tackling Inequity Strategy 2025-2030 is committed to addressing these disparities. For instance, women from South Asian backgrounds are disproportionately affected by gestational diabetes and are nearly twice as likely to develop type 2 diabetes afterward compared to women from White backgrounds. However, research often lumps South Asian communities together, overlooking the cultural, religious, and linguistic nuances that shape health outcomes. That's why we're funding a project led by Ifra Ali at the University of Warwick, who is exploring the care experiences of British-Pakistani women with gestational diabetes during and after pregnancy. By listening to these women's perspectives, Ifra aims to develop tailored healthcare solutions that address their unique needs, potentially reducing their long-term risk of type 2 diabetes. But here's a controversial interpretation: Could cultural sensitivity in healthcare sometimes lead to unintended generalizations? We'd love to hear your thoughts.
Together, we're unlocking new possibilities to improve the lives of people affected by diabetes, bringing hope for new treatments and a cure closer than ever. None of this would be possible without your unwavering support. Thank you for being a part of this transformative journey. What aspect of our research excites you the most? Let us know in the comments!
